Kronos Bio Inc. (KRON)
NASDAQ: KRON
· Real-Time Price · USD
0.88
0.01 (1.49%)
At close: Jun 20, 2025, 9:43 AM
Kronos Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.36M | -25.81M | -14.11M | -16.2M | -29.96M | -25.32M | -31.37M | -29.74M | -26.24M | -31.78M | -32.26M | -32.9M | -36.26M | -62.33M | -33.6M | -29.05M | -26.09M |
Depreciation & Amortization | 220K | 409K | -385K | 420K | 1.27M | 478K | 510K | 579K | 569K | 574K | 571K | 564K | 557K | 546K | 523K | 464K | 444K |
Stock-Based Compensation | 140K | 1.66M | 2.03M | 2.2M | 3.33M | 5.17M | 6.3M | 6.91M | 6.61M | 7.69M | 7.46M | 8.21M | 7.79M | 7.4M | 7.14M | 6.43M | 5.24M |
Other Working Capital | -7.07M | -6.39M | 11.6M | -2.06M | -9.94M | -2.09M | 993K | -1.44M | 12.57M | -2.65M | 3.44M | 1.99M | -630K | -3.31M | 3.33M | 365K | 1.19M |
Other Non-Cash Items | 3.07M | 16.18M | -11.79M | 542K | 14.58M | 9.27M | 752K | 796K | -456K | 20K | 267K | 1.01M | 1.39M | 891K | 533K | 688K | 477K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -9.33M | -1.37M | 1.43M | n/a | n/a | n/a | n/a | n/a | 822K | 1.1M | 1.13M | 943K |
Change in Working Capital | -7.91M | -5.27M | 11.89M | -3.29M | -8.59M | -5.29M | 2.6M | -5M | 13.57M | 971K | 1.56M | 604K | 3.04M | -5.85M | 4.17M | 76K | -14K |
Operating Cash Flow | -12.84M | -12.84M | -12.37M | -16.33M | -23.9M | -25.02M | -22.59M | -25.02M | -5.95M | -22.53M | -22.39M | -22.52M | -23.48M | -58.52M | -20.14M | -20.26M | -19M |
Capital Expenditures | n/a | -4K | 7K | n/a | -7K | -31K | -214K | -308K | -126K | -52K | -73K | -86K | -366K | -478K | -926K | -1.35M | -1.5M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -31.59M | -36M | -5.68M | 6.23M | -31.79M | -3.18M | 40.64M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -4.45M | -10.46M | -23.62M | -6.4M | -48.75M | -42.14M | -30.5M | -37.73M | -102.59M | -59.94M | -91.06M | -121.57M | -94.54M | -14.12M | -22.42M | -15.14M | -126.06M |
Sales Maturities Of Investments | 24.3M | 32.82M | 40.74M | 46.58M | 54.53M | 73.73M | 66.5M | 43.41M | 96.37M | 91.73M | 94.24M | 80.93M | 68.57M | 53.35M | 73.44M | 79.52M | 39.42M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 5.78M | 31.59M | 36M | 5.68M | -6.23M | 31.79M | 3.18M | -40.64M | -25.97M | 39.23M | 51.02M | 64.38M | -86.64M |
Investing Cash Flow | 19.85M | 22.36M | 17.13M | 40.18M | 5.77M | 31.56M | 35.79M | 5.37M | -6.36M | 31.74M | 3.11M | -40.73M | -26.34M | 38.75M | 50.09M | 63.03M | -88.15M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K |
Common Stock Repurchased | n/a | n/a | 162K | n/a | n/a | 538K | n/a | n/a | n/a | -716K | n/a | n/a | n/a | 521K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 82K | -1K | 164K | n/a | 191K | n/a | 376K | n/a | -716K | 628K | 410K | 529K | 1.05M | 1.38M | 1.44M | n/a |
Financial Cash Flow | n/a | 82K | -1K | 164K | n/a | 191K | n/a | 376K | n/a | -716K | 628K | 410K | 529K | 1.05M | 1.38M | 1.44M | 585K |
Net Cash Flow | 7.01M | 9.61M | 4.76M | 24.01M | -18.13M | 6.73M | 13.2M | -19.27M | -12.3M | 8.49M | -18.66M | -62.84M | -49.29M | -18.72M | 31.34M | 44.21M | -106.56M |
Free Cash Flow | -12.84M | -12.84M | -12.36M | -16.33M | -23.91M | -25.05M | -22.8M | -25.33M | -6.07M | -22.58M | -22.47M | -22.61M | -23.85M | -59M | -21.07M | -21.61M | -20.5M |